COMPANY

Reinventing the concept of
personalized medicine.

About Us


AttisLab Inc. is a biotechnology company that develops personalized medicine and drug screening platforms based on 3D organoid technology.

As a company established with the vision of developing personalized medicine, our research is focused on creating a complete personalized process from patient-derived disease modeling to cell therapy and treatment selection.
01
Personalized cell therapy development for chronic disease
02
Personalized cancer treatment platform development
03
Personalized clone organ development

Milestones

AttisLab Inc. was established as a leading company in the field of 3D organoids in 2019.

  • 2021
    - Investment from Seoul Techno Holdings, Inc.
    - TIPS Selection
    - Research Collaboration with Kangwon National University
    - Clinical trial contract with Grida Plastic Surgery Clinic
  • 2020
    - Received angel and institution investment
    - Research project assigned by Ministry of Food and Drug Safety
    - Research project assigned by Ministry of Education
    - Accredited as company-affiliated research institute
  • 2019
    - Assigned project by Ministry of Science, ICT and Future Planning
    - Accredited by Korea Technology Finance Corporation and Venture In
    - Began organoid research/development
    - Company founded

Our Team

Founded by world-class researchers with cutting-edge cancer biology and stem cell culture technology

Dong Ha Bhang, DVM, Ph.D
CEO & Co-founder
  • CEO, Biattic Inc.
  • Research Professor, School of Medicine, Sungkyunkwan University
  • Research fellow, Perelman School of Medicine, University of Pennsylvania
  • Externship, Cornell University Companion Animal Hospital
  • Ph.D. (Veterinary Medicine) Seoul National University
Sandra W Ryeom, Ph.D
CTO & Co-founder
  • Professor, Perelman School of Medicine, University of Pennsylvania
  • Assistant Professor, Harvard Medical School
  • Research fellow, Perelman School of Medicine, University of Pennsylvania
  • Ph.D. (Cell Biology and Genetics) Cornell University
Sam S. Yoon, MD
CSO & Co-founder
  • Surgical Oncologist, Memorial Sloan Kettering Cancer Center
  • Fellowships, Surgical Oncology, Memorial Sloan Kettering Cancer Center
  • Residencies, General Surgery, Massachusetts General Hospital
  • MD, University of California San Diego
Kwan-Hyuck Baek, Ph.D
CSO & Co-founder
  • Professor, School of Medicine, Sungkyunkwan University
  • Research fellow, Harvard Medical School
  • Ph.D. (Cell Immunology) Pohang University of Science and Technology
Ralf Michael Jakobs
CFO
  • CFO, DBI AG
  • CFO, co.don AG
  • QuantFS GmbH, (Gallinat-Service GmbH, Gallinat Bank AG)
  • J.D., Frankfurt University
Thorsten Sperber, M.Sc.
Vice President
  • CEO, International Life Science Consulting
  • Executive Director/VP, Immunomedics, Inc.
  • Executive Director, Celgene Corporation
  • M.Sc.(Molecular Biology), Westfalian Wilhelm’s University
Jae-Hee Lee, Ph.D
Researcher
  • Senior Research Investigator, Perelman School of Medicine, University of Pennsylvania
  • Ph.D. (Physiology) College of Medicine, Wonkwang University
Byung Gak Kim, Ph.D
Researcher
  • Director, Biattc Inc.
  • Research fellow, Perelman School of Medicine, University of Pennsylvania
  • Ph.D. (Animal Biotechnology) Chung-Ang University
Hunjoo Lee, M.Sc.
Head of IT
  • CEO, Inkarusell Inc.
  • Senior consultant, Penta Security Systems Inc.
  • Research Engineer, Sybase Korea Ltd
  • MS.c (Computer Science) Sogang University
Yong-Hee Kim, Ph.D
Researcher
  • Senior Research, Molecular and Cellular Biology, Sungkyunkwan University
  • Research fellow, The Gurdon Institute, University of Cambridge
  • Ph.D. (Animal Biotechnology) Chung-Ang University
Jiseok Kim, M.Sc. Candidate
Head of Design
  • Creative Director, Mr. Jones Association
  • Human-Computer-Interaction, KAIST
  • Graphic Design, Central Saint Martins
Yeong-Kyung Yoo, Ph.D Candidate
Researcher
  • Researcher, Hematology and oncology, Samsung Medical Center
  • Ph.D (Bioinspried Science) Ihwa Woman’s University-Candidate

Contact


AttisLab Inc. is a biotechnology company that develops personalized medicine and drug screening platforms based on 3D organoid technology.

3rd Floor, D-2, 538, Daedeok-daero, Yuseong-gu, Daejeon, Republic of Korea

info@attislab.com
※ All images and videos © AttisLab Inc. All rights reserved. Any illegal use/reproduction of this content will result in immediate legal action.
©2021 AttisLab Inc. All rights reserved.